Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06681428 · ClinicalTrials.gov registry record · NA
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
A NA study of Diabetic Foot Ulcer (DFU) and Chronic Foot Ulcers, sponsored by Tides Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 9
- Study locations
NCT06681428: Recruiting NA study of Diabetic Foot Ulcer (DFU) and Chronic Foot Ulcers, sponsored by Tides Medical.
NCT06681428 is a NA study of Diabetic Foot Ulcer (DFU) and Chronic Foot Ulcers that is actively recruiting participants, run by Tides Medical. The registered enrollment target is 240 participants, below the 500-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target (52% lower). The trial reports 9 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06681428, a NA study of Diabetic Foot Ulcer (DFU) and Chronic Foot Ulcers, is actively recruiting participants, sponsored by Tides Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.
Primary Outcome
Percentage of index ulcers (the ulcers being treated in the study) healed at 12 weeks
Conditions Studied
Interventions
- OTHER Allograft
Study Locations (9)
California
- Limb Preservation Platform Inc - Fresno
- Angel City Research - Los Angeles
- Clemente Clinical Research - Los Angeles
- ILD Research Center - Vista
Ohio
- Lower Extremity Institute of Research and Therapy - Boardman
- Brock Liden DPM - Circleville
Florida
- Clever Medical Research - Miami
North Carolina
- Foot and Ankle Specialists of the Mid-Atlantic - Raleigh
Virginia
- Foot and Ankle Specialists of the Mid-Atlantic - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-11-14 |
| Est. Completion | 2026-11-18 |
| Phase | NA |
What NCT06681428 shows while recruiting
NCT06681428 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 500-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target (52% lower).
The record links to 2 conditions, with Diabetic Foot Ulcer (DFU) appearing as the primary indexed condition, and to 1 intervention - of which Allograft is the first listed.
NCT06681428 lists 9 locations in 5 states (California, Ohio, Florida).
Frequently Asked Questions
What is clinical trial NCT06681428 about?
NCT06681428 is a clinical study titled "Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers". The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic foot ulcers (DFU) after ...
What is the current status of trial NCT06681428?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2024-11-14. Estimated completion is 2026-11-18.
What conditions does trial NCT06681428 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer (DFU), Chronic Foot Ulcers.
What interventions are being tested in trial NCT06681428?
The interventions under investigation include: Allograft (OTHER).
Who is sponsoring clinical trial NCT06681428?
This trial is sponsored by Tides Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06681428 being conducted?
This trial has 9 study locations across California, Florida, North Carolina, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer (DFU)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06681428's enrollment target sits among peer trials
240 7th of 13 higher than 7 of 13 other Diabetic Foot Ulcer (DFU) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer (DFU) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CARE-D-FOOT-Nav Pilot
RECRUITING · NA
-
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
RECRUITING · NA
-
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations
RECRUITING · NA
-
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
RECRUITING · NA
-
Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers
RECRUITING · NA
-
Remote Temperature and Visual Monitoring To Help Manage Diabetic Foot Ulcers
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI